A novel microfluidic co-culture system for investigation of bacterial cancer targeting.

Although bacterial cancer targeting in animal models has been previously demonstrated and suggested as a possible therapeutic tool, a thorough understanding of the mechanisms responsible for cancer specificity would be required prior to clinical applications. To visualize bacterial preference for cancer cells over normal cells and to elucidate the cancer-targeting mechanism, a simple microfluidic platform has been developed for in vitro studies. This platform allows simultaneous cultures of multiple cell types in independent culture environments in isolated chambers, and creates a stable chemical gradient across a collagen-filled passage between each of these cell culture chambers and the central channel. The established chemical gradient induces chemotactic preferential migration of bacteria toward a particular cell type for quantitative analysis. As a demonstration, we tested differential bacterial behavior on a two-chamber device where we quantified bacterial preference based on the difference in fluorescence intensities of green fluorescence protein (GFP)-expressing bacteria at two exits of the collagen-filled passages. Analysis of the chemotactic behavior of Salmonella typhimurium toward normal versus cancer hepatocytes using the developed platform revealed an apparent preference for cancer hepatocytes. We also demonstrate that alpha-fetoprotein (AFP) is one of the key chemo-attractants for S. typhimurium in targeting liver cancer.

[1]  N. Forbes,et al.  Bacterial therapies: completing the cancer treatment toolbox. , 2008, Current opinion in biotechnology.

[2]  M. Wei,et al.  Bacterial targeted tumour therapy-dawn of a new era. , 2008, Cancer letters.

[3]  W. Falk,et al.  Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α , 2009, PloS one.

[4]  H. Mao,et al.  A sensitive, versatile microfluidic assay for bacterial chemotaxis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Yoon,et al.  Fluorescence affinity sensing by using a self-contained fluid manoeuvring microfluidic chip. , 2008, The Analyst.

[6]  P. Celec,et al.  Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy , 2011, Gene Therapy.

[7]  Minseok S. Kim,et al.  Microfluidic device for analyzing preferential chemotaxis and chemoreceptor sensitivity of bacterial cells toward carbon sources. , 2011, The Analyst.

[8]  R. Ahrens,et al.  Diffusion- and convection-based activation of Wnt/β-catenin signaling in a gradient generating microfluidic chip. , 2012, Lab on a chip.

[9]  Arul Jayaraman,et al.  Investigation of bacterial chemotaxis in flow-based microfluidic devices , 2010, Nature Protocols.

[10]  N. Forbes Engineering the perfect (bacterial) cancer therapy , 2010, Nature Reviews Cancer.

[11]  R. Sainson,et al.  Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. , 2003, Microvascular research.

[12]  Rachel W. Kasinskas,et al.  Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro , 2006, Biotechnology and bioengineering.

[13]  M. Hayman,et al.  Involvement of the epidermal growth factor receptor in the invasion of cultured mammalian cells by Salmonella typhimurium , 1992, Nature.

[14]  S. Ryder Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults , 2003, Gut.

[15]  J. Adler,et al.  Negative Chemotaxis in Escherichia coli , 1974, Journal of bacteriology.

[16]  Meng Yang,et al.  Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer , 2007, Proceedings of the National Academy of Sciences.

[17]  A. Iwasaki,et al.  Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  Heon-Ho Jeong,et al.  Pump-less static microfluidic device for analysis of chemotaxis of Pseudomonas aeruginosa using wetting and capillary action. , 2013, Biosensors & bioelectronics.

[19]  E. Ruoslahti,et al.  Effects of ricin A chain conjugates of monoclonal antibodies to human alpha-fetoprotein and placental alkaline phosphatase on antigen-producing tumor cells in culture. , 1985, Cancer research.

[20]  R. Jain,et al.  Can engineered bacteria help control cancer? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Pfeifer,et al.  Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Jung-Joon Min,et al.  Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals , 2008, Nature Protocols.

[23]  J. Yoo,et al.  Quantitative analysis of single bacterial chemotaxis using a linear concentration gradient microchannel , 2009, Biomedical microdevices.

[24]  J. Saurat,et al.  The Antibacterial Activity of Topical Retinoids: The Case of Retinaldehyde , 2002, Dermatology.

[25]  P. Lambin,et al.  Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated salmonella , 2006, Cancer biology & therapy.

[26]  N. Minton Clostridia in cancer therapy , 2003, Nature Reviews Microbiology.

[27]  Rachel W. Kasinskas,et al.  Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. , 2007, Cancer research.

[28]  J. Adler A method for measuring chemotaxis and use of the method to determine optimum conditions for chemotaxis by Escherichia coli. , 1973, Journal of general microbiology.

[29]  Jungyul Park,et al.  Concentration gradient generation of multiple chemicals using spatially controlled self-assembly of particles in microchannels. , 2012, Lab on a chip.

[30]  S. Weiss,et al.  Salmonella—allies in the fight against cancer , 2010, Journal of Molecular Medicine.

[31]  P. Kristjansen,et al.  Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay. , 2004, Microvascular research.